Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
INDV compared with VISN: revenue, margins and what each company keeps, and the suppliers and customers both name
INDV
Indivior Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
VISN
Vistance Networks, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
INDV
Indivior Pharmaceuticals, Inc.
vs
VISN
Vistance Networks, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
VISN: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only INDV
5
AQST
Aquestive Therapeutics
supplier
ADXN
Addex Therapeutics
supplier
—
Curia New Mexico
unlisted
supplier
—
Reckitt Benckiser Healthcare (U.K.)
unlisted
supplier
1 more · INDV chain
›
Shared
0
No shared counterparties.
Only VISN
19
—
Undisclosed top customer
unlisted
customer
—
Undisclosed top direct customer
unlisted
customer
GOOGL
Google Cloud Platform (GCP)
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
MSFT
Microsoft Azure (Azure)
supplier
15 more · VISN chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
INDV, solid
VISN, dashed
INDV
Indivior Pharmaceuticals, Inc.
Change
36.36
▲
+2.81%
Mkt cap
$4.2B
Revenue
$356M
Q3 FY26
Revenue
$1.2B
FY25
VISN
Vistance Networks, Inc.
Change
6.53
▼
−0.23%
Regular session
Nov 2 '26
Mkt cap
$1.5B
Revenue
$320M
Q2 FY26
Revenue
—
vs
Compare
Regular session
Nov 2 '26
INDV
Indivior Pharmaceuticals, Inc.
vs
VISN
Vistance Networks, Inc.
36.36
▲
+2.81%
Price
6.53
▼
−0.23%
$4.2B
Mkt cap
$1.5B
Q3 FY26
$356M
Revenue
$320M
Q2 FY26
FY25
$1.2B
Revenue
—
Change
Change
INDV
36.36
▲
+2.81%
vs
VISN
6.53
▼
−0.23%
Regular session
Nov 2 '26